Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Archbow Consulting announced Justine Hughes has been promoted to EVP of principal operations while Honora Gabriel and Rob ...

Global commercial executive with expertise across product lifecycle and therapeutic areas leading transformative brands, ...

The Thurgood Marshall College Fund has received a $25 million grant by the Lilly Endowment to help fund its HBCU-focused ...

Project HBCU Capacity Building consists of three strategies ... Jr., through gifts of stock in their pharmaceutical business, Eli Lilly and Company. While those gifts remain the financial bedrock ...

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

Oppenheimer reiterated an Outperform rating on Veru Inc. (NASDAQ:VERU), which has seen remarkable momentum with a 200% return over the past year and a 96% gain year-to-date. Anticipation is building ...

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...